Green Vision Biotechnology CORP.: management transactions · United States · SEC (Form 4)

About Green Vision Biotechnology CORP.

GREEN VISION BIOTECHNOLOGY CORP. is a United States-incorporated company with a long and complex corporate history, best understood today as a small-cap, high-risk issuer with an agricultural and green-products orientation rather than a traditional large biotechnology platform. The company was incorporated in Nevada on July 5, 2012, originally under the name Any Translation Corp., and its early business focus was translation and interpretation services. It later changed its name to Vibe Wireless Corp. and then to Green Vision Biotechnology Corp. in 2016, reflecting a strategic repositioning toward environmentally oriented products and agricultural applications. According to SEC materials, GVBT describes itself as a pioneer in the research and development of green products, particularly bio-fertilizers for the agricultural sector in the People’s Republic of China, and it has also stated an intention to expand into trading agricultural products, cold storage, and related logistics activities. The company’s business address has been referenced in Hong Kong, underscoring that although it is legally organized in the United States, its operational footprint has been largely Asia-facing. From a competitive standpoint, GVBT appears to operate in a niche segment where scale, distribution access, and execution matter more than brand recognition. It does not appear to have the profile of a major NYSE or NASDAQ growth name; rather, it has the characteristics of a thinly followed micro-cap with a limited public information footprint. One of the most important recent developments is that the company announced in 2022 that it would voluntarily file Form 15 to suspend its SEC reporting obligations, citing a desire to reduce compliance costs and preserve resources for business operations and potential corporate transactions. That move materially reduces transparency versus fully reporting U.S.-listed peers. For investors, the key takeaways are the company’s incorporation in the United States, its evolving business model centered on agricultural bio-products and logistics, its Hong Kong-linked operating structure, and its recent emphasis on cost reduction and strategic flexibility. In short, GREEN VISION BIOTECHNOLOGY CORP. should be viewed as a small, restructuring-oriented agricultural biotech story with limited disclosure, not as a mainstream listed biotech company on NYSE or NASDAQ.